This web app uses cookies to compile statistic information of our users visits. By continuing to browse the site you are agreeing to our use of cookies. If you wish you may change your preference or read about cookies

close
Gilead Sciences business model | How does Gilead Sciences make money?

Gilead Sciences, Inc., incorporated on June 22, 1987, is a research-based biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of medicines in areas of unmet medical need. The Company's principal areas of focus include human immunodeficiency virus (HIV), liver diseases, such as chronic hepatitis C virus (HCV) infection and chronic hepatitis B virus (HBV) infection, cardiovascular health, hematology/oncology, and inflammation/respiratory illness.

Visit website

Average rate:
4.5

Number of votes:
1070

Digital maturity:
Beginner

Embed code:

x